Follow
Radwa Sharaf
Radwa Sharaf
Foundation Medicine
Verified email at foundationmedicine.com
Title
Cited by
Cited by
Year
Helicobacter pylori: a poor man's gut pathogen?
MM Khalifa, RR Sharaf, RK Aziz
Gut pathogens 2 (1), 1-12, 2010
2812010
Mechanisms and therapeutic implications of hypermutation in gliomas
M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ...
Nature 580 (7804), 517-523, 2020
2152020
Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy
KB Einkauf, GQ Lee, C Gao, R Sharaf, X Sun, S Hua, SMY Chen, C Jiang, ...
The Journal of clinical investigation 129 (3), 988-998, 2019
1502019
Contaminated water as a source of Helicobacter pylori infection: A review
RK Aziz, MM Khalifa, RR Sharaf
Journal of advanced research 6 (4), 539-547, 2015
1262015
The control of HIV after antiretroviral medication pause (CHAMP) study: posttreatment controllers identified from 14 clinical studies
G Namazi, JM Fajnzylber, E Aga, RJ Bosch, EP Acosta, R Sharaf, ...
The Journal of infectious diseases 218 (12), 1954-1963, 2018
1102018
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers
R Sharaf, GQ Lee, X Sun, B Etemad, LM Aboukhater, Z Hu, ZL Brumme, ...
The Journal of clinical investigation 128 (9), 4074-4085, 2018
582018
Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response
M Montesion, K Murugesan, DX Jin, R Sharaf, N Sanchez, A Guria, ...
Cancer Discovery 11 (2), 282-292, 2021
512021
Peripheral blood–derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency
M Schmueck-Henneresse, R Sharaf, K Vogt, BJD Weist, ...
The Journal of Immunology 194 (11), 5559-5567, 2015
362015
Effect of short-term antiretroviral therapy interruption on levels of integrated HIV DNA
Z Strongin, R Sharaf, DJ VanBelzen, JM Jacobson, E Connick, ...
Journal of virology 92 (12), e00285-18, 2018
312018
The alphabet soup of HIV reservoir markers
RR Sharaf, JZ Li
Current HIV/AIDS Reports 14 (2), 72-81, 2017
312017
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
EA Williams, S Santagata, H Wakimoto, GM Shankar, FG Barker, R Sharaf, ...
Acta neuropathologica communications 8 (1), 1-10, 2020
222020
HIV-1 balances the fitness costs and benefits of disrupting the host cell actin cytoskeleton early after mucosal transmission
SM Usmani, TT Murooka, M Deruaz, WH Koh, RR Sharaf, M Di Pilato, ...
Cell host & microbe 25 (1), 73-86. e5, 2019
142019
Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations
EA Williams, M Montesion, N Shah, R Sharaf, DC Pavlick, ES Sokol, ...
Modern Pathology 33 (12), 2397-2406, 2020
122020
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles
EA Williams, N Shah, M Montesion, R Sharaf, DC Pavlick, ES Sokol, ...
Modern Pathology 33 (8), 1466-1474, 2020
112020
Vulvar squamous cell carcinoma: Comprehensive genomic profiling of HPV+ versus HPV–forms reveals distinct sets of potentially actionable molecular targets
EA Williams, AJ Werth, R Sharaf, M Montesion, ES Sokol, DC Pavlick, ...
JCO Precision Oncology 4, 647-661, 2020
112020
CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma
EA Williams, M Montesion, R Sharaf, J Corines, PJ Patel, BJ Gillespie, ...
Modern Pathology 33 (12), 2614-2625, 2020
92020
Large syncytia in lymph nodes induced by CCR5-tropic HIV-1
TT Murooka, RR Sharaf, TR Mempel
AIDS research and human retroviruses 31 (5), 471-472, 2015
92015
Visualizing the behavior of HIV-infected T cells in vivo using multiphoton intravital microscopy
R Sharaf, TR Mempel, TT Murooka
HIV Protocols, 189-201, 2016
72016
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response. Cancer …
M Montesion, K Murugesan, DX Jin, R Sharaf, N Sanchez, A Guria, ...
CD-20-0672, 0
7
Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
LB Giron, CS Palmer, Q Liu, X Yin, E Papasavvas, R Sharaf, B Etemad, ...
Nature Communications 12 (1), 1-15, 2021
62021
The system can't perform the operation now. Try again later.
Articles 1–20